申请人:Hoffmann-La Roche Inc.
公开号:US05393875A1
公开(公告)日:1995-02-28
The compounds of the formula ##STR1## wherein A, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 have the significance given in claim 1, in the form of optically pure diastereomers, mixtures of diastereomers, diastereomeric racemates or mixtures of diastereomeric racemates as well as pharmaceutically usable salts thereof inhibit the activity of the natural enzyme renin and can accordingly be used in the form of pharamaceutical preparations in the control or prevention of high blood pressure and cardiac insufficiency. They can be manufactured according to various methods which are known per se.
式子为##STR1##的化合物,其中A,R.sup.1,R.sup.2,R.sup.3,R.sup.4和R.sup.5的含义如权利要求1所述,以光学纯的对映异构体、对映异构体混合物、对映异构体外消旋体或对映异构体外消旋体混合物的形式存在,并且其药用盐可以抑制天然酶肾素的活性,因此可以用作药物制剂,用于控制或预防高血压和心脏衰竭。它们可以按照已知的各种方法制备。